monocrotaline has been researched along with Cardiac Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Gao, X; Guo, Q; Peng, Y; Wang, E; Yang, Y; Ye, Z; Zhang, F; Zhu, M | 1 |
| Booth, FW; Lees, SJ; Steffen, BT | 1 |
| Hilliker, KS; Roth, RA | 1 |
3 other study(ies) available for monocrotaline and Cardiac Diseases
| Article | Year |
|---|---|
C-Type Natriuretic Peptide Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction in Rats with Pulmonary Arterial Hypertension.
Topics: Animals; Cyclic GMP; Heart Diseases; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lipopolysaccharides; Male; Monocrotaline; Natriuretic Peptide, C-Type; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2018 |
Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Topics: Animals; Anorexia; Blotting, Western; Body Weight; Cachexia; Eating; Enzyme-Linked Immunosorbent Assay; Gene Expression; Heart Diseases; Male; Monocrotaline; Muscle, Skeletal; Organ Size; Pentoxifylline; Poisons; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tumor Necrosis Factor Inhibitors; Ubiquitin; Weight Loss | 2008 |
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogenase; Lung; Lung Diseases; Monocrotaline; Myocardium; Organ Size; Pyrrolizidine Alkaloids; Rats; Sulfinpyrazone | 1984 |